Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C
- 15 September 2009
- journal article
- case report
- Published by Wiley in Journal of Hospital Medicine
- Vol. 4 (7), E45-E46
- https://doi.org/10.1002/jhm.452
Abstract
Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52‐year‐old woman, who developed pneumonitis with exudative, lymphocytic‐predominant pleural effusion following treatment with pegylated IFN alpha and ribavirin for hepatitis C. Her symptoms and lung findings resolved over 3 months of observation without corticosteroid therapy. Journal of Hospital Medicine 2009;4:E45–E46. © 2009 Society of Hospital Medicine.Keywords
This publication has 3 references indexed in Scilit:
- Spectrum of Pulmonary Toxicity Associated with the Use of Interferon Therapy for Hepatitis C: Case Report and Review of the LiteratureClinical Infectious Diseases, 2004
- Fatality and interferon α for malignant melanomaThe Lancet, 1998
- Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alphaThorax, 1997